Immunicum: Q2 report and a New CEO
Research Note
2020-08-28
10:48
Redeye views the appointment of a permanent CEO as an important step to improve sentiment around the shares as well as facilitate the implementation of corporate strategy. Moreover, the new CEO seems like a good fit with Immunicum’s current focus, we believe.
NE
Niklas Elmhammer
Disclosures and disclaimers